Cellebrite DI .(CLBT)
icon
搜索文档
Cellebrite and Relativity Deliver Solutions to Transform the Mobile Data Collection Landscape
GlobeNewswire News Room· 2024-11-20 21:30
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Cellebrite (Nasdaq: CLBT), a global leader in premier digital investigative solutions for the public and private sectors, and Relativity, a global legal technology company, announced today the general availability of the integration of Cellebrite’s mobile collection solutions, Endpoint Inspector and Endpoint Mobile Now, into the RelativityOne platform. The need for mobile collection in legal processes continues to grow and this ne ...
NU or CLBT: Which Is the Better Value Stock Right Now?
ZACKS· 2024-11-12 01:45
文章核心观点 - 对于寻求科技服务行业股票的投资者来说Nu Holdings Ltd. (NU)和Cellebrite DI Ltd. (CLBT)可供选择通过对比发现Nu Holdings Ltd.在多项指标上表现更优价值投资者可能会认为Nu Holdings Ltd.是更好的选择[1][7] Nu Holdings Ltd.相关要点 - 有Zacks Rank为2 (Buy)表明其盈利预期近期有正向修正盈利前景改善[3] - 有一系列估值指标如forward P/E ratio为37.15 PEG ratio为0.69 P/B ratio为10.48 Value grade为B[5][6] Cellebrite DI Ltd.相关要点 - 有Zacks Rank为3 (Hold)[3] - 估值指标forward P/E为44.66 PEG ratio为1.95 P/B为12.85 Value grade为D[5][6]
Cellebrite DI: Long-Term Growth Looks Positive, But Valuation Increased
Seeking Alpha· 2024-11-12 01:43
David focuses on growth & momentum stocks that are reasonably priced and likely to outperform the market over the long-term. He is a long term investor of quality stocks and uses options for strategy. David told investors to buy in March 2009 at the bottom of the financial crisis. The S&P 500 increased 367% and the Nasdaq increased 685% from 2009 through 2019. He wants to help make people money by investing in high-quality growth stocks.Analyst’s Disclosure: I/we have no stock, option or similar derivative ...
Cellebrite: There Are Potential Risks That Could Damper Growth
Seeking Alpha· 2024-11-08 22:22
I gave a buy rating to Cellebrite (NASDAQ: CLBT ) in August as I believed the upside is no longer attractive given that valuation has risen to 31x forward EBITDA. Looking at how the share price hasI'm a passionate investor with a strong foundation in fundamental analysis and a keen eye for identifying undervalued companies with long-term growth potential. My investment approach is a blend of value investing principles and a focus on long-term growth. I believe in buying quality companies at a discount to th ...
Cellebrite DI .(CLBT) - 2024 Q3 - Earnings Call Transcript
2024-11-07 04:44
财务数据和关键指标变化 - 公司在2024年第三季度实现了106.8百万美元的收入,首次季度收入超过1亿美元,同比增长27% [38] - 年度经常性收入(ARR)增长26%,达到371百万美元,毛保留率约为91% [36] - 第三季度调整后的EBITDA为31.3百万美元,EBITDA利润率为29%,较去年同期的25%有所提升 [41] 各条业务线数据和关键指标变化 - Insights产品线推动了大部分ARR增长,Guardian和Pathfinder产品线也做出了贡献 [36] - Guardian在过去12个月内增长超过100%,显示出SaaS解决方案的强劲需求 [19] 各个市场数据和关键指标变化 - 美洲市场占总ARR的54%,EMEA占34%,亚太地区占12% [37] - 美洲市场ARR增长26%,EMEA增长24%,亚太地区增长31% [37] 公司战略和发展方向和行业竞争 - 公司计划在2025年前将Insights的客户采用率从10%提高到15% [18] - 公司正在扩大与美国联邦政府的关系,Cellebrite Federal Solutions已全面运营 [13] - 公司致力于通过云计算和AI技术提升产品能力,以满足日益复杂的执法需求 [21][29] 管理层对经营环境和未来前景的评论 - 管理层对2024年的前景持乐观态度,预计将再次提高收入和调整后的EBITDA目标 [31] - 管理层认为,执法机构对数字转型的需求将持续推动公司增长 [116] 其他重要信息 - 公司在第三季度完成了10.1百万股新普通股的发行,优化了资本结构 [22][44] - 公司CEO Yossi Carmil将在2024年底卸任,寻找新任CEO的过程已启动 [56][66] 问答环节所有提问和回答 问题: 新任CEO的选拔过程 - 新任CEO的选拔将不局限于地理位置,目标是找到最佳领导者 [70] 问题: CyTech收购对本季度的贡献 - CyTech的贡献非常有限,本季度略低于50万美元 [69] 问题: 关于C2C平台的采用预期 - 预计到2025年,Insights的采用率将继续增长,当前约有300个客户采用了两种或三种旗舰产品 [80] 问题: 关于联邦市场的表现 - 联邦市场在2023年底占公司总业务的20%,并预计在2025年将看到初步的财务收益 [94] 问题: 关于AI在解决方案中的应用 - 客户对AI能力的重视程度很高,AI技术显著提高了调查速度和效率 [102]
Cellebrite DI Ltd. (CLBT) Tops Q3 Earnings and Revenue Estimates
ZACKS· 2024-11-06 22:25
文章核心观点 - 公司第三季度业绩超出市场预期,每股收益为0.14美元,高于市场预期的0.11美元[1] - 公司营收为1.0686亿美元,也超出市场预期[2] - 公司连续4个季度业绩和收入均超出市场预期[2] - 公司股价今年以来上涨121.1%,大幅跑赢大盘[3] 行业和公司分析 行业分析 - 公司所属的技术服务行业目前在250多个行业中排名前34%[8] - 行业排名前50%的公司业绩普遍优于后50%的公司2倍以上[8] 公司分析 - 公司未来业绩表现将主要取决于管理层在财报电话会议上的评论[3] - 分析师对公司未来几个季度和本财年的业绩预期有所上调[7] - 同行Block公司第三季度业绩也有望同比大幅增长[9][10]
Yossi Carmil to Step Down as CEO After Nearly 20 Years
GlobeNewswire News Room· 2024-11-06 21:20
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced a planned leadership transition following Yossi Carmil’s decision to step down from his current role as CEO and as a member of the Board of Directors by December 31, 2024. The Board has initiated a formal search for a new CEO, retaining an executive recruiting firm to advance this effort. Thomas ...
What Makes Cellebrite DI Ltd. (CLBT) a New Strong Buy Stock
ZACKS· 2024-10-15 01:01
Cellebrite DI Ltd. (CLBT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices. The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by th ...
Cellebrite to Report Third-Quarter 2024 Financial Results on November 6, 2024
GlobeNewswire News Room· 2024-10-10 20:30
文章核心观点 - 公司将于2024年11月6日发布第三季度财务业绩报告 [1][2] - 公司将在当天上午8:30举行财报电话会议和网络直播,回顾第三季度财务业绩并讨论2024年全年展望 [2] - 公司是全球领先的数字调查解决方案提供商,为公共和私营部门客户提供服务,帮助他们掌握合法数字调查的复杂性,提高情报处理效率 [3] 财报会议信息 - 日期:2024年11月6日 [2] - 时间:美东时间上午8:30 [2] - 电话号码:203-518-9766 [2] - 会议ID:CLBTQ324 [2] - 网络直播链接:https://edge.media-server.com/mmc/p/skb7gjeh [2] - 财务数据和补充信息将在公司投资者关系网站发布 [2]
Cellebrite DI Ltd. (CLBT) Hit a 52 Week High, Can the Run Continue?
ZACKS· 2024-10-08 22:20
文章核心观点 - 公司股价在过去一个月内上涨7.7%,创下52周新高,今年以来股价上涨104.2% [1] - 公司连续4个季度业绩超预期,最近一季度EPS和收入均超预期 [2] - 公司当前和未来一年的业绩预期良好,EPS和收入均有较大幅度增长 [2] 公司情况总结 - 公司估值指标显示其估值较同行偏高,但仍有一定上涨空间 [3][4] - 公司当前评级为买入评级,未来有进一步上涨的潜力 [5] - 同行公司Distribution Solutions Group表现也较为出色,行业整体前景良好 [6][7]